Carl Ng
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 9
- Oncology 8
- HER2/EGFR in Cancer Research 7
- CAR-T cell therapy research 2
- Peptidase Inhibition and Analysis 1
- Cancer Treatment and Pharmacology 1
- Co-authors
- Keyang Xu (5 shared papers)Dian Su (3 shared papers)Shang‐Fan Yu (4 shared papers)Surinder Kaur (3 shared papers)Thomas H. Pillow (4 shared papers)Valerie Quarmby (3 shared papers)Rachana Ohri (2 shared papers)Mehraban Khosraviani (1 shared paper)
- Journals
- Analytical Chemistry (3 papers)mAbs (2 papers)Journal of Immunological Methods (2 papers)Drug Metabolism and Disposition (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Carl Ng
10 papers receiving 236 citations
Peers
Comparison fields: 5 of 38
- Radiology, Nuclear Medicine and Imaging 185
- Immunology 104
- Oncology 132
- Molecular Biology 144
- Spectroscopy 19
Countries citing papers authored by Carl Ng
This map shows the geographic impact of Carl Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Ng more than expected).
Fields of papers citing papers by Carl Ng
This network shows the impact of papers produced by Carl Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Ng. The network helps show where Carl Ng may publish in the future.
Co-authors
The 25 scholars most cited alongside Carl Ng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 74 | |
| 2 | 2017 | 47 | |
| 3 | 2014 | 43 | |
| 4 | 2016 | 42 | |
| 5 | 2008 | 20 | |
| 6 | 2020 | 13 | |
| 7 | 2013 | 10 | |
| 8 | 2020 | 8 | |
| 9 | 2022 | 7 | |
| 10 | 2020 | 2 |
About Carl Ng
Carl Ng is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Organic Chemistry, having authored 10 papers that have together received 266 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (7 papers), Biosimilars and Bioanalytical Methods (3 papers), CAR-T cell therapy research (2 papers), Protein purification and stability (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer Treatment and Pharmacology (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (185 citations), Immunology (104 citations), Oncology (132 citations), Molecular Biology (144 citations) and Spectroscopy (19 citations). Carl Ng has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Keyang Xu, Dian Su, Shang‐Fan Yu, Surinder Kaur, Thomas H. Pillow, Valerie Quarmby, Rachana Ohri, Mehraban Khosraviani, Ely Cosino and Zhi-jie Jey Cheng. Their work appears in journals such as Analytical Chemistry, mAbs, Journal of Immunological Methods, Drug Metabolism and Disposition and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.